Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U.S. MedSys Corp. was a development-stage healthcare company that specialized in medical technology and support services. The company's primary business involved the marketing and distribution of medical products, with a significant focus on diabetic supplies and orthotic devices through its subsidiary, Global Medical Direct. U.S. MedSys sought to create a comprehensive medical network to improve the delivery of healthcare services and products to patients and providers. During its peak in the mid-2000s, the company was publicly traded on the OTC Bulletin Board under the ticker UMSY, but it has since ceased active operations following financial and legal challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U.S. MedSys.